Filing Details
AMARIN CORP PLC\UK (NASDAQ:AMRN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 28, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:AMRN
AMARIN CORP PLC\UK (AMRN) Files Quarterly Report for Q0
AMARIN CORP PLC\UK (NASDAQ:AMRN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 28, 2026.
At publication ·
What changed
AMARIN CORP PLC\UK (NASDAQ:AMRN) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Amarin Corp PLC filed its quarterly report on October 28, 2026, with the SEC as required for public companies.
- The company's stock trades at $12.74 with a market capitalization of $285.4 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
AMARIN CORP PLC\UK's stock currently trades at $12.74 with a market capitalization of $285.4M.
The 10-Q provides AMARIN CORP PLC\UK's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for AMARIN CORP PLC\UK are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AMRN Stock Page
Frequently Asked Questions
Where can I read AMRN's SEC filings?
Browse all filings on our AMRN SEC filings page.
What types of SEC filings does AMARIN CORP PLC\UK file?
Public companies like AMARIN CORP PLC\UK file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.